Winnexa Health Sciences Private Limited
About Winnexa Health Sciences Private Limited
Data last updated:
Winnexa Health Sciences Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 October 2023.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U46497MP2023PTC067934.
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors Bharat Jaswani and Krishna Jaswani.
Its last annual general meeting (AGM) was held on 08 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Indore, Madhya Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.38 Cr, a growth of 115% compared to the previous year. For the same year it recorded a net profit of ₹6.94 Lakh (net margin 0.9%) and EBITDA of ₹37.98 Lakh (EBITDA margin 5.1%).
As per MCA filings, the company has open charges of ₹18 Lakh on record.
Company details
Contact details
Winnexa Health Sciences Private Limited's registered office is in Indore, Madhya Pradesh.
- Registered Address460 Scheme No. 78 Part 1, Phase 2 (Industrial Comm), Indore, Madhya Pradesh, India – 452010
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Winnexa Health Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Winnexa Health Sciences Private Limited, buy the company report.
Financials of Winnexa Health Sciences Private Limited
FY 2025 filings availableWinnexa Health Sciences Private Limited reported revenue of ₹7.38 Cr (up 115% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 115% in the latest year. EBITDA rose 66% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹37.98 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹6.94 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 5.1% | |
| Net Profit Margin | 0.9% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Winnexa Health Sciences Private Limited, buy the company report.
Board of directors of Winnexa Health Sciences Private Limited
Winnexa Health Sciences has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bharat Jaswani | Director | 03 Oct 2023 | 3 Years 0 Months | Current |
| Krishna Jaswani | Director | 03 Oct 2023 | 3 Years 0 Months | Current |
Peer comparison
Winnexa Health Sciences Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Asvin Diagnostics Private Limited | ₹7.42 Cr (FY 2025) | 23.0% | Jaipur, Rajasthan, India | |||
| JBR Pharmaceutical Private Limited | ₹7.42 Cr (FY 2024) | 2796.0% | Anjar, Gujarat, India | |||
| Acventa Private Limited | ₹7.4 Cr (FY 2024) | 1852.0% | Delhi, India | |||
| Winnexa Health Sciences Private Limitedthis company | ₹7.38 Cr (FY 2025) | ₹6.94 Lakh | 0.9% | 115.0% | Indore, Madhya Pradesh, India | |
| Immugen Lifesciences Private Limited | ₹7.38 Cr (FY 2023) | -25.0% | Nagpur, Maharashtra, India | |||
| Navodaya Pharmaceuticals Private Limited | ₹7.38 Cr (FY 2024) | -19.0% | Noida, Uttar Pradesh, India | |||
| Arrier Biotech Private Limited | ₹7.36 Cr (FY 2025) | 40.0% | Ambala, Haryana, India |
To see the full peer comparison of Winnexa Health Sciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 May 2024 | 100923122 | State Bank of India | ₹18 Lakh | Open |
To see the full charge records of Winnexa Health Sciences Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Winnexa Health Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Winnexa Health Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Winnexa Health Sciences Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Winnexa Health Sciences Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Bharat Jaswani was appointed as Director on 03 Oct 2023.
Frequently asked questions
Winnexa Health Sciences is an active private limited company based in Indore, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 October 2023 (3+ years old) and is registered under CIN U46497MP2023PTC067934.
Winnexa Health Sciences has 2 current directors:
- Bharat Jaswani - Director
- Krishna Jaswani - Director
The latest financial statements of Winnexa Health Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 08 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Winnexa Health Sciences is U46497MP2023PTC067934. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Winnexa Health Sciences was incorporated on 03 October 2023, making it 3+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Winnexa Health Sciences by revenue are Asvin Diagnostics Private Limited, JBR Pharmaceutical Private Limited, Acventa Private Limited, Immugen Lifesciences Private Limited, Navodaya Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Bharat Jaswani was appointed as Director on 03 Oct 2023. Krishna Jaswani was appointed as Director on 03 Oct 2023.
The registered office of Winnexa Health Sciences is at 460 Scheme No. 78 Part 1, Phase 2 Industrial Comm, Indore, Madhya Pradesh, India – 452010.
Winnexa Health Sciences operates in the pharma industry, in the drug formulation and development segment.
Winnexa Health Sciences has open charges of ₹18 Lakh and no satisfied charges on record as per latest MCA filings.
Winnexa Health Sciences can be reached at its registered office: 460 Scheme No. 78 Part 1, Phase 2 Industrial Comm, Indore, Madhya Pradesh, India – 452010.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
